Clinical trial
Mycophenolate Mofetil in Myasthenia Gravis
NCT00285350 · FDA Office of Orphan Products Development, U.S. Fed · Completed
Key facts
| NCT number | NCT00285350 |
|---|---|
| Title | Mycophenolate Mofetil in Myasthenia Gravis |
| Official title | A Trial of Mycophenolate Mofetil in Myasthenia Gravis |
| Lead sponsor | FDA Office of Orphan Products Development, U.S. Fed |
| Collaborators | Duke University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myasthenia Gravis |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil |
| Enrollment | 80 |
| Start date | Sep 1, 2002 |
| Completion | Mar 1, 2007 |
| First posted | Feb 2, 2006 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: